Shashank Sirsi
Associate Professor
shashank.sirsi@utdallas.edu
Phone: 972-883-4939
Office: BSB 13.909
800 West Campbell Rd.
Mailstop: BSB11
Richardson, TX 75080-3021
Education
BS, Biomedical Engineering, University of California, San Diego, 2002
PhD, Biomedical Engineering, Drexel University, 2007
Overview
Dr. Sirsi grew up in California and attended the University of California, San Diego, where he majored in Biomedical Engineering. As an undergraduate, Dr. Sirsi performed research in a physiology lab in the Veterans hospital, where he studied the biomechanics of single muscle fibers. Dr. Sirsi graduated with a BS in 2002 and continued his research at Drexel University, where he designed novel polymer vectors for nucleic acid delivery to dystrophic muscle tissue. He received his PhD in Biomedical Engineering in 2007 and gravitated towards cancer research during his first postdoctoral position at Columbia University in New York.
Dr. Sirsi grew up in California and attended the University of California, San Diego, where he majored in Biomedical Engineering. As an undergraduate, Dr. Sirsi performed research in a physiology lab in the Veterans hospital, where he studied the biomechanics of single muscle fibers. Dr. Sirsi graduated with a BS in 2002 and continued his research at Drexel University, where he designed novel polymer vectors for nucleic acid delivery to dystrophic muscle tissue. He received his PhD in Biomedical Engineering in 2007 and gravitated towards cancer research during his first postdoctoral position at Columbia University in New York.
As a postdoctoral researcher, Dr. Sirsi designed and tested novel ultrasound contrast agents for in vivo imaging and targeted drug delivery to tumors using pediatric neuroblastoma models. In 2010, Dr. Sirsi moved to the University of Colorado at Boulder and continued his cancer work as a Research Associate. He was awarded an NIH R21 grant in 2012 to support his research on image-guided drug delivery to tumor tissue. He subsequently worked as a senior research scientist at MIT and the ETH University in Switzerland, using ultrasound contrast agents for MRI-guided focused ultrasound drug delivery to the brain.
During his academic tenure, Dr. Sirsi has published over 20 research articles, 2 book chapters, and has been awarded 3 patents.
Research Interests
Cancer research, ultrasound imaging and image-guided drug delivery, ultrasound contrast agents development